ETS Wound Care LLC is a privately held medical device company developing next generation treatments for wound healing focused on using borate-based bioactive glass technology. ETS Wound Care products compete in the advanced wound healing market and provide clinicians with a new wound healing treatment therapy. ETS Wound Care is a subsidiary company of Engineered Tissue Solutions (ETS), a holdings company focused on “Healing People to Help People,”
ETS Wound Care was founded in Rolla, Missouri, USA to develop and commercialize 100% synthetic wound care products composed of proprietary resorbable borate-based bioactive glass. The borate glass technology was innovated by researchers at the Missouri University of Science and Technology while investigating novel ways to heal soft tissue injuries. The borate-based bioactive glass technology platform is now composed of over 14 issued U.S. and foreign patents with additional filings pending. From this technology, ETS Wound Care has developed the first FDA cleared inorganic bioactive glass based wound care solution.